|
Real-time Estimate
Cboe BZX
14:50:52 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 22.88 USD | -2.64% |
|
-1.60% | -50.71% |
| 10-19 | Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million | MT |
| 10-09 | Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 746M | - | - | |||
| 1,165B | |||||
| 645B | |||||
| 504B | |||||
| 380B | |||||
| 363B |
Select your edition
All financial news and data tailored to specific country editions
